CONMEDCNMD
CNMD
About: Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Geographically operates in USA, Europe, Middle East & Africa, Asia Pacific and North America. Majority is revenue is from USA.
Employees: 3,900
0
Funds holding %
of 7,312 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
2,854% more call options, than puts
Call options by funds: $9.81M | Put options by funds: $332K
10% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 41
4% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 94
1% less funds holding
Funds holding: 278 [Q4 2024] → 276 (-2) [Q1 2025]
0.78% less ownership
Funds ownership: 115.86% [Q4 2024] → 115.08% (-0.78%) [Q1 2025]
12% less capital invested
Capital invested by funds: $2.45B [Q4 2024] → $2.15B (-$302M) [Q1 2025]
100% less funds holding in top 10
Funds holding in top 10: 2 [Q4 2024] → 0 (-2) [Q1 2025]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$55
7%
upside
Avg. target
$58
13%
upside
High target
$61
19%
upside
4 analyst ratings
0 positive
0%
4 neutral
100%
0 negative
0%
Needham Mike Matson | 19%upside $61 | Hold Downgraded | 12 Jun 2025 |
JP Morgan Robbie Marcus | 13%upside $58 | Neutral Maintained | 1 May 2025 |
Wells Fargo Vik Chopra | 11%upside $57 | Equal-Weight Maintained | 1 May 2025 |
Stifel Rick Wise | 7%upside $55 | Hold Downgraded | 28 Apr 2025 |
Financial journalist opinion
Based on 3 articles about CNMD published over the past 30 days
Positive
Zacks Investment Research
1 day ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
Neutral
Business Wire
4 days ago
Martha Aronson to Step Down from CONMED Board of Directors Following Appointment as President and Chief Executive Officer of Merit Medical Systems, Inc.
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Martha Aronson will be stepping down from the company's Board of Directors to assume the role of President and Chief Executive Officer at Merit Medical, a global leader in the development, manufacture and distribution of proprietary medical devices. Mrs. Aronson's resignation from the Board will be effective July 7, 2025, as she transitions to her new leadership responsibilities. “We are sincerely grateful to Mar.
Neutral
Business Wire
1 week ago
CONMED Corporation to Announce Second Quarter 2025 Financial Results on July 30, 2025
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2025 after the market close on Wednesday, July 30, 2025. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via telephone, please click here to pre-register and obtain the dial-in number and passcode. This conference call will also be webcast and can be accessed fro.
Positive
Zacks Investment Research
1 month ago
Conmed (CNMD) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
1 month ago
Here's Why You Should Retain CONMED Stock in Your Portfolio for Now
CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.
Neutral
Business Wire
1 month ago
CONMED Corporation Appoints LaVerne Council as Chair of the Board of Directors
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that LaVerne Council has been appointed to succeed Martha Goldberg Aronson as the new Independent Chair of its Board of Directors, effective May 21, 2025. “LaVerne's extensive experience as a global operations and information technology executive have been invaluable to CONMED, and I know that her experience will continue to serve the Board and the Company well in her new role as Chair of the Board,” said Pat Beyer, P.
Neutral
Business Wire
1 month ago
CONMED Corporation Announces Quarterly Cash Dividend
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors declared a quarterly cash dividend of $0.20 per share on May 20, 2025, payable on July 3, 2025, to all shareholders of record as of June 13, 2025. About CONMED Corporation CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company's products are used by surgeons and other healthcare professionals in a variety of specialties, including ort.
Positive
Zacks Investment Research
1 month ago
Here's Why Conmed (CNMD) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
2 months ago
Why Conmed (CNMD) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Positive
Zacks Investment Research
2 months ago
CNMD Stock Up On Q1 Earnings & Sales Beat, Raised 2025 Outlook
CNMD reports solid first-quarter results, driven by improving sales across both segments.
Charts implemented using Lightweight Charts™